Sodium Iodide (I-123) Curium Netherlands

Sodium Iodide (I-123) is a radiopharmaceutical used in nuclear medicine imaging. This sterile, non-pyrogenic solution helps diagnose thyroid and other conditions. It is administered intravenously for precise imaging results. Suitable for adults and children as directed by a healthcare provider.

Sodium Iodide (I-123) is primarily used for diagnostic imaging of the thyroid gland. It helps evaluate thyroid function and detect abnormalities such as nodules or cancer. The radiopharmaceutical is also used in whole-body scans to assess metastatic thyroid disease. Healthcare professionals determine its use based on individual patient needs.

After administration, Sodium Iodide (I-123) localizes in the thyroid gland, emitting gamma rays for imaging. Patients may experience mild discomfort at the injection site. The radiopharmaceutical is designed to provide clear images for diagnostic purposes. Effects are temporary and resolve as the substance is cleared from the body.

Sodium Iodide (I-123) should be handled with care due to its radioactive properties. Pregnant or breastfeeding individuals should avoid exposure. Patients must follow healthcare provider instructions regarding preparation and post-procedure care. Avoid close contact with others for a specified period as advised.

Certain medications, such as thyroid hormones or antithyroid drugs, may interfere with the uptake of Sodium Iodide (I-123). Patients should inform their healthcare provider about all medications and supplements. Contrast agents or iodine-containing products may also affect imaging results. Timing of administration may need adjustment based on these factors.